Aug 11, 2020
Study Suggests Potential Role for Laser Ablation in Glioblastoma Treatment, Monteris Medical Announces
Jun 22, 2020
Kazia Presents Further Paxalisib and Cantrixil Data at AACR, Reinforcing Positive Efficacy Signals for both Drugs
Jun 22, 2020
DelMar Pharmaceuticals Presents Positive Interim Data on VAL-083 Demonstrating Favorable Outcomes in Both Newly- Diagnosed and Recurrent GBM at the AACR Virtual Annual Meeting II
Jun 11, 2020
CNS Announces the FDA has Granted Orphan Drug Designation for Brain Cancer Drug Berubicin
Jun 10, 2020
MemorialCare Long Beach Medical Center Now Offers Varian Edge(TM) - the Fastest, Most Precise Radiation Treatment Available
Jun 09, 2020
CNS Announces Highlights from Annual Meeting of Shareholders
Jun 04, 2020
TVAX Biomedical Receives Fast Track Designation from the FDA for Brain Cancer
Jun 04, 2020
Global Coalition for Adaptive Research (GCAR) Selects DelMar Pharmaceuticals' VAL-083 to Participate in the GBM AGILE Pivotal Study, an Adaptive Clinical Trial Platform in Glioblastoma Multiforme
Jun 03, 2020
Clarity Pharmaceuticals Announces that the US FDA Grants Rare Pediatric Disease Designation to 67Cu-SARTATE(TM) for the Treatment of Neuroblastoma
Jun 02, 2020
NW Bio Provides Update On Projected Timing For Data Lock For Phase 3 Trial of DCVax®-L for Glioblastoma Brain Cancer
Jun 01, 2020
DelMar Pharmaceuticals to Present Updates of Two Phase 2 Clinical Trials of VAL-083 at the 2020 American Association for Cancer Research Virtual Annual Meeting II
May 29, 2020
Medicenna Updates Efficacy Results from Phase 2b Recurrent GBM Trial at ASCO 2020
May 27, 2020
CNS Announces Common Stock Will Resume Trading on the NASDAQ on May 28, 2020
May 27, 2020
Biotech Brief: Global Glioblastoma Multiforme Drug Market Could Exceed $1.4 Billion by 2025
May 24, 2020
Art of Surviving, Global Online Art Exhibition, Launches in Honor of Brain Tumor Awareness Month
May 21, 2020
I-Mab and Genexine Announce China NMPA Clearance for Phase 2 Clinical Trial of TJ107/HyLeukin-7(TM) in Glioblastoma Multiforme
May 19, 2020
Hoag is First in Nation to Test Innovative Antibody Brain Cancer Drug
May 18, 2020
CNS Announces Nasdaq Trading Halt Pending Receipt of Additional Information
May 05, 2020
DelMar Pharmaceuticals [Nasdaq:DMPI] Provides Enrollment Update in Phase 2 Clinical Trial of VAL-083 for Adjuvant Treatment of Brain Tumors
Apr 23, 2020
The Brain Race Announces Winning Startups in Position to Defeat Brain Tumors